CSIMarket Company Name, Ticker, Competitors, else..
 
Telesis Bio Inc   (TBIO)
 
Price: $0.0010 $0.00 0.000%
Day's High: $0.0010000000474974513 Week Perf: 0.00
Day's Low: $ 0.00 30 Day Perf: -9.09 %
Volume (M): 1,500 52 Wk High: $ 0.15
Volume (M$): $ 0 52 Wk Avg: $0.03
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) 0
 Shares Outstanding (Millions) 2
 Employees 11
 Revenues (TTM) (Millions $) 12
 Net Income (TTM) (Millions $) -46
 Cash Flow (TTM) (Millions $) -14
 Capital Exp. (TTM) (Millions $) 1

Business Description


The company is an early-stage technology firm specializing in multi-omic and synthetic biology. It develops products including BioXp systems, BioXp kits, and benchtop reagents to support the screen-design-build-test process in synthetic biology. The company operates within the synthetic biology market, focusing on research, development, and commercialization of related products.


   Company Address: 10421 Wateridge Circle San Diego 92121 CA
   Company Phone Number: 228-4115   Stock Exchange / Ticker: TBIO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
A        0.08% 
AVTR        1.96% 
BRKR        1.81% 
ILMN   -4.3%    
MTD        0.45% 
RVTY        4.61% 
• View Complete Report
   



Product Service News

DNA & mRNA Synthesis Transformed Telesis Bio and Beckman Coulter Life Sciences Forge Revolutionary Path in...

Published Wed, Sep 25 2024 8:06 PM UTC

In a groundbreaking development poised to reshape the landscape of synthetic biology, Telesis Bio, a pioneer in automated biofoundry solutions, and Beckman Coulter Life Sciences, a global leader in laboratory automation and instrumentation, have announced a collaborative effort. This alliance is set to revolutionize DNA and mRNA synthesis, delivering unprecedented capabiliti...
Product Service News

Telesis Bio Announces Commercial Release of Cell-free Amplification Kit for Generation of Transfection-scale DNA

Published Fri, Nov 3 2023 4:00 PM UTC


Telesis Bio, a leading biotechnology company, has recently unveiled its innovative Cell-free Amplification Kit, designed to expedite the process of generating transfection-scale DNA. This groundbreaking kit offers a BioXp automation workflow, enabling researchers to go from candidate sequence to amplified DNA in a matter of days.
The Cell-free Amplification Kit addr...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.00
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.56
Working Capital Ratio 1.23
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -17.85 $
Revenues (TTM) 6.88 $
Cash Flow (TTM) -
Cash 2.1 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 1,108,182
Net Income per Employee (TTM) -4,141,000
Receivable Turnover Ratio (TTM) 4.21
Inventory Turnover Ratio (TTM) 2.98
Asset Turnover Ratio (TTM) 0.23

Profitability Ratios Current
Gross Margin (MRQ) 64.43 %
Operating Margin (MRQ) -349.74 %
Net Margin (MRQ) -424.14 %
Net Cash Flow Margin (MRQ) -170.95 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.